Status:
COMPLETED
Amplification of Merkel Cell Polyomavirus From Skin Swabs
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Polyomavirus
Eligibility:
All Genders
18+ years
Brief Summary
Background: * Polyomavirus are DNA-based viruses that infect vertebrates, including humans. Most people are not harmed by polyomavirus infection, but people with compromised immune systems may be har...
Detailed Description
Polyomaviruses are a class of DNA-based viruses that infect vertebrates, including humans. A majority of humans are chronically infected with multiple polyomavirus types. In immunocompetent subjects, ...
Eligibility Criteria
Inclusion
- Study participants will be drawn from LCO co-workers in Building 37 Rooms 4106-4134. LCO members will be invited to participate without regard to gender, race, sexual orientation, or ethnic background.
Exclusion
Key Trial Info
Start Date :
August 25 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 19 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00977990
Start Date
August 25 2009
End Date
May 19 2010
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892